TNFSF13B and Peri-Implantitis: In this feasibility study, CCL-20/MIP-3α, BAFF/BLyS, IL-23, RANKL, and Osteoprotegerin concentrations were assessed in patients diagnosed with peri-implant health, peri-implant mucositis and peri-implantitis.